Site icon Tishha News

Aster DM Eyes $150 Million Hospital Acquisition from Narayana in Northern India

image 19
Connect with us

Blackstone-backed Aster DM Quality Care Ltd. is reportedly in discussions to acquire hospital assets from Narayana Hrudayalaya Ltd. as part of its strategy to strengthen its presence in northern India, according to people familiar with the matter.

The proposed transaction could be valued at up to $150 million, although negotiations are ongoing and the final deal structure may change or the discussions may not result in an agreement.

Private Equity Drives Healthcare Consolidation

The potential acquisition reflects increasing investor interest in India’s hospital sector, where consolidation has gained momentum. Private equity firms, including Blackstone, KKR, TPG, Advent International, General Atlantic and Singapore-based Temasek Holdings, have invested more than $10 billion in Indian hospitals over the past five years, according to earlier Bloomberg reports.

Aster DM has identified acquisitions as an important part of its expansion strategy. The company was also previously in discussions to invest in Yatharth Hospital Ltd., before Advent International acquired a 25% stake in the Delhi-based hospital chain for ₹31.5 billion ($337 million) in September.

Blackstone Strengthens Its Bet on Aster DM

Blackstone holds approximately 30% of Aster DM and described the healthcare company as one of its top 10 global investments in September.

Aster DM and Blackstone declined to comment on the reported acquisition discussions. Narayana Hrudayalaya Vice Chairman Viren Shetty also declined to comment, citing market speculation and rumours.

Competitive Pressure in Northern India

The reported discussions come amid competitive challenges in northern India’s hospital market. During an earnings call in May 2026, Narayana Vice Chairman Viren Shetty described the region as an extremely challenging market for the company.

He noted that Narayana was a relatively recent entrant in the region and faced competition from hospital chains pursuing more aggressive expansion strategies. Although the company had developed capabilities in cancer treatment and other specialised medical services, Shetty indicated that these strengths alone were not sufficient to compete with established players.

If completed, the proposed transaction could support Aster DM’s expansion in northern India while adding another significant deal to the ongoing consolidation of the country’s hospital sector.

Subscribe TISHHA

Exit mobile version